omena

High-Level Overview

Omena Technologies is a Paris-based femtech startup founded in 2021 that develops a mobile app for menopause management, offering personalized programs, educational content, and a community for women experiencing symptoms like hot flashes, sleep issues, anxiety, and depression.[1][5] The app serves women in healthcare, particularly in France where 500k enter menopause annually, solving the underserved need for accessible support and information on symptoms, treatments, and risks such as breast cancer and cardiovascular diseases.[1][5] It has raised $1.3M total, including an €800k seed round in 2023 (€600k equity) from business angels, family offices, and investors like Fair Equity and Mozza Angels, with strong early traction: 55k users since March 2022 launch and 10% converting to paid memberships.[1][5] Formerly WEMPO, it's in debt stage and alive, featured in CB Insights' Digital Health and Women's Health Tech collections.[1]

Origin Story

Omena was founded in 2021 by Nême, Hahyeon Park, and Jane Douat while they were business school students in Paris, initially as WEMPO before rebranding.[1][5] The idea emerged from recognizing the lack of attention to menopause—affecting 80% of women with varied symptoms—despite its massive scale, leading them to build a free app for symptom info, treatments, and risk awareness.[5] Early traction built quickly: pre-seed €400k in 2021, app launch in March 2022 gaining 55k accounts, and a pivotal €800k seed in 2023 amid tough femtech funding, driven by solid monetization metrics that attracted 45% female investors including Nabla founder Alexandre Lebrun.[5] Based in Neuilly-sur-Seine, France, this student-led pivot humanizes a critical women's health gap.[1][5]

Core Differentiators

• Targeted Menopause Focus: Unlike broad digital health apps, Omena delivers personalized programs for menopause-specific symptoms, education, and peer community, addressing an overlooked market in femtech.[1][5]
• Strong User Engagement and Monetization: 55k users with 10% paid conversion since 2022 launch, proving demand in a niche with high symptom prevalence (80% of women).[5]
• Community and Holistic Support: Combines info on treatments/risks with experience-sharing, fostering retention beyond basic tracking apps; plans include e-shop for vetted supplements and insurance partnerships.[5]
• Investor Backing and Metrics: €1.2M+ raised with diverse angels (nearly half women), positioning it for B2B growth like health insurer integrations.[1][5]

(Note: Shenzhen Omena Technology Co., Ltd., a separate Chinese trader of tools like laser meters and microscopes since ~2018, matches the name but not the "technology company" in healthtech context.[2][3][7])

Role in the Broader Tech Landscape

Omena rides the femtech wave in digital health, targeting women's health tech like menopause support amid rising VC interest in underserved areas (e.g., CB Insights' 711-company collection).[1] Timing aligns with post-pandemic health awareness and aging populations—France's 500k annual menopause cases highlight scalable demand—plus growing insurer focus on preventive care.[5] Market forces favor it: femtech funding rebounded despite 2023 challenges, with Omena's 10% paid users signaling viability; it influences the ecosystem by normalizing menopause tech, potentially expanding to affiliates and B2B like private insurance catalogs.[1][5] As part of 11k+ digital health innovators, it pushes beyond pharma toward app-based wellness.[1]

Quick Take & Future Outlook

Omena's momentum—55k users, solid conversions, and fresh seed—positions it for e-shop launches, insurer deals, and EU expansion, capitalizing on femtech's shift to monetizable niches.[5] Trends like AI personalization in health apps and women's health equity will propel it, potentially scaling to millions as menopause awareness grows. Its influence may evolve from app pioneer to ecosystem player via partnerships, tying back to its core mission: empowering an overlooked demographic in a high-potential market.[1][5]